History of paclitaxel or carboplatin hypersensitivity

Inadequate bone marrow function (Neutrophil\<1500/mm3, Platelet \<100,000/mm3)

Pregnancy or breast-feeding state

Metachronous or synchronous malignancy

Galactose intolerance, Lapp Lactase deficiency, or glucose-galactose malabsorption patients with genetic problems

Other patients who were judged difficult to be included in this investigation by the investigator in charge

Safety of Genexol PM and Carboplatin as First-line Therapy in Ovarian Cancer